MetaCap

Valion Bio Earnings

NASDAQ: VBIOHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD

0.4806-0.0593 (-10.98%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Valion Bio earnings summary

In its most recent report on Nov 20, 2026 (Sep/2026), VBIO posted EPS of $-49.25.

Summary generated from market data by MetaCap's automated system. Methodology

VBIO earnings history

Valion Bio reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Nov 20, 2026—$-49.25——
Nov 13, 2026—$-49.25—-9.2%
Aug 14, 2026—$-2.17——
May 14, 2026—$-2.23——
Mar 25, 2026—$-1.16——
Nov 14, 2025—$-1.97——
Aug 14, 2025—$-2.19——
May 15, 2025—$-2.52——
Mar 21, 2025—$3.07——
Nov 14, 2024—$-0.23——
Aug 14, 2024—$-5.37——
May 15, 2024—$-17.15——
Mar 25, 2024—$-157.64——
Nov 14, 2023—$-1.48——
Aug 14, 2023—$-7.16——
May 15, 2023—$-10.52——

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related